Skip to main content
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc — Investor Relations & Filings

Ticker · PTGX ISIN · US74366E1029 US Manufacturing
Open in API
Filings indexed 641 across all filing types
Latest filing 2016-08-01 Capital/Financing Update
Country US United States of America
Listing US PTGX

About Protagonist Therapeutics, Inc

https://www.protagonist-inc.com/

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company that specializes in the discovery and development of peptide-based new chemical entities. The company utilizes its proprietary technology platform to engineer novel oral and injectable peptide therapeutics. Its development pipeline is focused on creating treatments for rare and prevalent diseases, particularly in the areas of hematology and gastroenterology, addressing significant unmet medical needs.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 1 TO FORM S-1
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 1 to Form S-1 filed with the SEC, which is a registration statement for an initial public offering (IPO). It includes detailed information about the offering, the company, risk factors, use of proceeds, capitalization, management discussion, and financial data. Form S-1 is a registration statement used for securities offerings and is not a financial report like an annual or quarterly report. It is a capital markets filing related to fundraising and securities issuance. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS. Hence, the classification is CAP with high confidence.
2016-08-01 English
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a letter from legal counsel to the U.S. Securities and Exchange Commission regarding a Registration Statement on Form S-1 filed by Protagonist Therapeutics, Inc. The letter responds to SEC staff comments about accounting for equity issuances and stock compensation related to the IPO process. It includes detailed explanations of stock option grants, valuation methodologies, and fair value determinations. The document references the Registration Statement on Form S-1 and discusses confidential treatment requests. It is not the Registration Statement itself, nor is it a financial report like an Annual Report or Interim Report. Instead, it is a regulatory correspondence related to the registration filing process. Given the nature of the document as a regulatory submission and response letter to the SEC, it fits best under Regulatory Filings (RNS). The document is substantive and lengthy (15,000 characters), but it is not a financial report or earnings release. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2016-07-27 English
FORM S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated July 11, 2016, for Protagonist Therapeutics, Inc. It is a detailed registration statement for an initial public offering (IPO) of common stock. The text includes extensive information typical of an S-1 filing such as company overview, risk factors, use of proceeds, capitalization, dilution, selected financial data, management discussion and analysis, business description, executive compensation, principal stockholders, description of capital stock, underwriting, legal matters, and financial statements. The S-1 is a regulatory filing used to register securities for public sale and is not an annual report, earnings release, or other financial report. It is a capital markets document related to financing activities and fundraising. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the full filing, not just an announcement or summary.
2016-07-11 English
Regulatory Filings 2016
Regulatory Filings
2016-07-05 English
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from a company to the U.S. Securities and Exchange Commission (SEC) staff regarding comments on a Draft Registration Statement on Form S-1. The letter addresses specific SEC comments on disclosures, scientific terms, clinical trial details, risk factors, and financial information related to the company's IPO registration statement. The document references the Form S-1 registration process, which is a filing for securities registration prior to an IPO, and includes detailed responses to SEC staff comments on the draft prospectus. This type of document is a regulatory filing related to the registration statement process and is not itself a financial report, earnings release, or other report type. It is a formal regulatory correspondence responding to SEC comments on a registration statement. Therefore, the appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements, compliance documents, and miscellaneous filings that do not fit other categories.
2016-06-22 English
Capital/Financing Update 2016
Capital/Financing Update Classification · 95% confidence The document is a confidential draft registration statement submitted to the SEC on Form S-1 by Protagonist Therapeutics, Inc. It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of common stock. The document includes detailed information typical of an S-1 filing such as company overview, risk factors, use of proceeds, capitalization, management discussion, and financial data. This type of filing is a registration statement for securities offering, which is a capital raising activity. Therefore, it fits the category of Capital/Financing Update (CAP). It is not an annual report, earnings release, or any other category. The document length is substantial and contains detailed offering information, not just an announcement or a brief notice, so it is not RPA or RNS. Hence, the correct classification is CAP with high confidence.
2016-06-22 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.